324068-31-7 Usage
Chemical structure
Contains a sulfonamide group and a piperazine ring.
Unique molecular structure
Features a 4-chloro-3-nitrophenyl substituent attached to the sulfonamide group and a methyl substituent attached to the piperazine ring.
Potential applications
Pharmaceutical industry, particularly in the development of novel drugs with biological activities.
Building block
Can be used in the synthesis of various pharmacologically active molecules.
Biological activities
May exhibit its own biological activities, making it a subject of interest for medicinal chemistry research.
Versatility
Has potential pharmaceutical and medicinal properties due to its unique structure and potential applications.
Check Digit Verification of cas no
The CAS Registry Mumber 324068-31-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,4,0,6 and 8 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 324068-31:
(8*3)+(7*2)+(6*4)+(5*0)+(4*6)+(3*8)+(2*3)+(1*1)=117
117 % 10 = 7
So 324068-31-7 is a valid CAS Registry Number.
324068-31-7Relevant academic research and scientific papers
AMINOPYRIDINE DERIVATIVES FOR TREATING TUMORS AND INFLAMMATORY DISEASES
-
Page/Page column 55, (2012/05/20)
Compounds of the formula (I), in which R1, R2, R3, R4, R7 and Y have the meanings indicated in Claim 1, are inhibitors of PDK1 and cell proliferation/cell vitality and can be employed for the treatmen
QUINOXALINE DERIVATIVE
-
Page/Page column 141-142, (2009/10/01)
The invention discloses quinoxaline derivatives or salts thereof having PDE9-inhibiting activity and being useful as treating agent of dysuria and the like, which are represented by the formula (I) in the formula, R1 and R2 each inde
ARYLGLYCINE DERIVATIVES AND THEIR USE AS GLYCINE TRANSPORT INHIBITORS
-
Page 44, (2010/02/06)
The present invention relates to compounds of Formula (I), and salts solvates and hydrates thereof. The invention further relates to pharmaceutical compositions containing said compounds and methods of treating neurological, neuropsychiatric, and gastrointestinal disorders using said compounds.
